Hideki Enokida

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 77 Citations 14,543 295 World Ranking 13643 National Ranking 436

Overview

What are the main themes of his work throughout his whole career to date

In his papers, Hideki Enokida integrates diverse fields, such as Cancer and Cell growth. He undertakes interdisciplinary study in the fields of Cell growth and Gene through his works. In his works, Hideki Enokida conducts interdisciplinary research on Gene and In silico. He performs integrative study on Cancer research and Carcinogenesis. He undertakes interdisciplinary study in the fields of Carcinogenesis and Cancer research through his works. His work on In silico expands to the thematically related Genetics. Hideki Enokida performs integrative study on microRNA and Messenger RNA in his works. In his papers, Hideki Enokida integrates diverse fields, such as Messenger RNA and microRNA. His Bladder cancer study frequently draws connections to adjacent fields such as Transitional Cell.

Hideki Enokida most often published in these fields:

Cancer (77.78%)
Cancer research (66.67%)
Gene (66.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Small dsRNAs induce transcriptional activation in human cells

Long-Cheng Li;Steven T. Okino;Hong Zhao;Deepa Pookot.
Proceedings of the National Academy of Sciences of the United States of America (2006)

931 Citations

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

Masayuki Kano;Naohiko Seki;Naoko Kikkawa;Lisa Fujimura.
International Journal of Cancer (2010)

531 Citations

Identification of novel microRNA targets based on microRNA signatures in bladder cancer.

Takahiro Ichimi;Hideki Enokida;Yasushi Okuno;Ryo Kunimoto.
International Journal of Cancer (2009)

490 Citations

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

T Chiyomaru;H Enokida;S Tatarano;K Kawahara.
British Journal of Cancer (2010)

379 Citations

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

H Yoshino;T Chiyomaru;H Enokida;K Kawakami.
British Journal of Cancer (2011)

303 Citations

microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers

Nijiro Nohata;Toyoyuki Hanazawa;Hideki Enokida;Naohiko Seki.
Oncotarget (2012)

262 Citations

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

Yasutoshi Yamada;Hideki Enokida;Satoko Kojima;Kazumori Kawakami.
Cancer Science (2011)

261 Citations

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR

Takeshi Chiyomaru;Soichiro Yamamura;Shinichiro Fukuhara;Hirofumi Yoshino.
PLOS ONE (2013)

256 Citations

Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway

Shinji Urakami;Hiroaki Shiina;Hideki Enokida;Toshifumi Kawakami.
Clinical Cancer Research (2006)

244 Citations

Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.

Takashi Tokizane;Hiroaki Shiina;Mikio Igawa;Hideki Enokida.
Clinical Cancer Research (2005)

240 Citations

If you think any of the details on this page are incorrect, let us know.